Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene-edited pigs are resistant to PRRS, study finds
PRRS is an economically devastating disease that costs the pig industry some $2.5 billion in the US and Europe alone.

Results show potential of technique to benefit the pork industry

Scientists have used gene-editing techniques to create pigs that are resistant to Porcine Reproductive and Respiratory Syndrome (PRRS).

In a first-of-its-kind study, researchers exposed these pigs to the virus to see if they became infected. They found that none of the pigs became ill when exposed to the virus, nor did blood tests find any trace of infection.

Dr Christine Tait-Burkard, of the University of Edinburgh’s Roslin Institute, said the results were exciting but stressed that it will still be many years before we’ll be producing food from PRRS-resistant pigs.

“First and foremost we need broader public discussion on the acceptability of gene-edited meat entering our food chain, to help inform political leaders on how these techniques should be regulated,” she said. “We also need to carry out long-term studies to confirm that these genetic changes do not have any unforeseen adverse effects on the animals.

PRRS is an economically devastating disease that costs the pig industry some $2.5 billion in the US and Europe alone. Most vaccines have not been successful in preventing the spread of the virus, which continues to evolve.

The virus infects pigs using a receptor in their cells’ surface called CD163. Researchers at the University of Edinburgh’s Roslin Institute used gene-editing techniques to remove a small section of this gene.

Previous studies have shown that cells from these animals were resistant to the virus in lab tests. But this is the first time researchers have exposed these pigs to the virus to see if they become infected.

The study was funded by the Biotechnology and Biological Sciences Research Council and Genus PLC and is published in the Journal of Virology.

Genus chief scientific officer Jonathan Lightner said: “These results are very exciting and further underscore the potential, through gene editing, to provide incredible benefits to the global pork industry, and society as a whole, by improving animal health.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.